US20170246379A1 - System and method for detecting presence of an infusion cartridge in an infusion pump - Google Patents
System and method for detecting presence of an infusion cartridge in an infusion pump Download PDFInfo
- Publication number
- US20170246379A1 US20170246379A1 US15/467,500 US201715467500A US2017246379A1 US 20170246379 A1 US20170246379 A1 US 20170246379A1 US 201715467500 A US201715467500 A US 201715467500A US 2017246379 A1 US2017246379 A1 US 2017246379A1
- Authority
- US
- United States
- Prior art keywords
- pwm commands
- infusion pump
- infusion
- commands
- operational
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 106
- 238000000034 method Methods 0.000 title claims abstract description 39
- 238000005086 pumping Methods 0.000 claims abstract description 19
- 230000007246 mechanism Effects 0.000 claims description 52
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 20
- 239000012530 fluid Substances 0.000 description 19
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229960003611 pramlintide Drugs 0.000 description 1
- 108010029667 pramlintide Proteins 0.000 description 1
- NRKVKVQDUCJPIZ-MKAGXXMWSA-N pramlintide acetate Chemical compound C([C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 NRKVKVQDUCJPIZ-MKAGXXMWSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/148—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
- A61M5/152—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags pressurised by contraction of elastic reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/14—Detection of the presence or absence of a tube, a connector or a container in an apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16809—Flow controllers by repeated filling and emptying of an intermediate volume
Definitions
- Insulin-injecting pumps have been developed for the administration of insulin for those suffering from both type I and II diabetes.
- Continuous subcutaneous insulin injection and/or infusion therapy with portable infusion device has been adapted for the treatment of diabetes.
- Such therapy may include the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen.
- Such pumps can be ambulatory/portable infusion pumps that are worn by the user that may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. patent application Ser. No. 13/557,163, U.S. patent application Ser. No. 12/714,299, U.S. patent application Ser. No.
- Some commercially available pumps may have an interchangeable infusion cartridge containing insulin and/or other medicaments.
- the correct attachment of this interchangeable infusion cartridge is important for the proper delivery of medicament. For instance, the cartridge may inadvertently become detached or may not be attached to the pump, resulting in possible inaccuracies in treatment and other issues.
- the method may include installing an infusion cartridge in an infusion pump, initiating an infusion cartridge loading sequence, recording loading pulse width modulation (PWM) commands applied to an infusion pump motor, setting a value of threshold PWM commands, comparing values of operational PWM commands applied during pumping operations to the value of the threshold PWM commands, and generating a missing cartridge indication whenever the value of an operational PWM command drops below the value of the threshold PWM commands by a predetermined amount.
- PWM pulse width modulation
- an infusion system may be configured for detecting a presence or absence of an infusion cartridge.
- the infusion system may include an infusion cartridge and an infusion pump.
- the infusion cartridge may include a delivery mechanism for effectuating delivery of fluid having an axial bore, a spool which may be disposed within the axial bore and axially translatable within the axial bore, and a drug delivery reservoir for storing fluid.
- the infusion pump may include a drive mechanism and a processor.
- the processor may be coupled to a memory configured for receiving input data from the memory and using input data for generating operational parameters for the infusion system. Programming may be stored in the memory for execution by a processor to control a closed-loop motor control algorithm.
- the closed-loop motor control algorithm may be configured for generating PWM commands that operate a motor of the drive mechanism, and to indicate an absence of the infusion cartridge if the value of the operational PWM command falls below the predetermined value the threshold PWM commands.
- FIG. 1 is a flowchart illustrating a method embodiment for detecting the presence of an interchangeable infusion cartridge in an infusion pump.
- FIG. 2 is an exploded view of an embodiment of an infusion cartridge and an infusion pump with the infusion cartridge removed from the infusion pump.
- FIG. 3 is a block diagram representing an embodiment of an infusion pump.
- FIG. 4 is an elevation view in partial section of a delivery mechanism embodiment of the infusion cartridge embodiment of FIG. 2 coupled to a drive mechanism embodiment.
- Some embodiments may include advances in the internal components, the control circuitry, and improvements in a user interface of the systems and devices. The advances may allow for a safer and more accurate delivery of medicament to a patient than is currently attainable today from other devices, systems, and methods.
- embodiments described herein may be discussed in the context of the controlled delivery of insulin, delivery of other medicaments, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated.
- Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, or any other suitable indication or application. Non-medical applications are also contemplated.
- PWM pulse width modulation
- PWM commands and PWM commands
- a value of PWM commands generally represents a duty cycle of the series of pulses during a command sequence. For example, if the PWM is 100% with an input voltage of 3.0 volts, the output will be 3.0 volts. If the PWM command is 50%, the output voltage of the same 3.0 volt input would be 1.5 volts.
- FIG. 2 depicts an embodiment of an infusion pump system 100 with an infusion cartridge 16 detached from the full-featured infusion pump device 12 .
- the pump 12 can include an attachment mechanism 64 , positioned within the first receiving slot 22 that corresponds to a receiving mechanism 62 at an end of the infusion cartridge 16 .
- the attachment and receiving mechanisms can be configured to removably couple to each other to provide for an interchange of cartridges within the slot 22 .
- the coupling keeps an interior of the cartridge and interior of the pump sealed from the surrounding environment such that fluid is retained within the volumes even under significant pressure.
- This attachment embodiment may be configured to produce a leak free detachable coupling that can withstand significant pressure.
- the receiving mechanism 62 may be configured to detachably couple with the attachment mechanism 64 such that the infusion cartridge 16 may be removably attached to the housing 26 of the infusion pump 12 for fluid delivery.
- the attachment mechanism 64 may include a pneumatic tap 66 having an O-ring or other sealing device.
- the corresponding receiving mechanism 62 may include a port through which the pneumatic tap 66 may be inserted.
- a reservoir fill port 76 may be disposed on a top portion of the infusion cartridge 16 .
- the desired fluid may be manually dispensed from the interior volume of a syringe or other source, through the reservoir fill port 76 and into the interior volume of the infusion cartridge 16 .
- FIG. 3 illustrates a block diagram of some features that may be incorporated within the housing 26 of the infusion pump 12 .
- the infusion pump 12 may include a memory device 30 , a transmitter/receiver 32 , an alarm 34 , a speaker 36 , a clock/timer 38 , an input device 40 , a processor 42 , a user interface such as a graphical user interface (GUI) 60 having a touch sensitive screen 46 with input capability, a drive mechanism 48 , and an estimator device 52 .
- the memory device 30 may be coupled to the processor 42 to receive and store input data, and to communicate that data to the processor 42 .
- the input data may include user input data and sensor input data.
- the input data from the memory device 30 may be used to generate operational parameters for the infusion pump 12 .
- the GUI 60 may be configured for displaying a request for the user to input data, for receiving user input data in response to the request, and communicating that data to the memory.
- the GUI 60 can also be configured to display a missing infusion cartridge indication/warning as discussed herein.
- the processor 42 can function to control the overall operation of the pump.
- Processor 42 may communicate with and/or otherwise control the drive mechanism, output/display, memory, transmitter/receiver, and the like.
- Processor 42 of the infusion pump may communicate with a processor of another device, such as a continuous glucose monitor, a remote controller/commander, etc.
- Processor 42 may include programming that can control the infusion of insulin or other medicament from the cartridge, the data to be displayed by the display, the data to be transmitted via the transmitter, etc. Part of the programming may be configured to control an electric motor 170 depicted in FIG. 4 .
- Processor 42 may also include programming that may allow the processor to receive signals and/or other data from an input device, such as a sensor sensing pressure, temperature, and the like.
- the processor 42 may be included as a part of infusion pump 12 or may be used in conjunction therewith.
- a motor control program may be stored in the memory 30 for retrieval by the processor 42 to operate a closed-loop motor control algorithm.
- the closed-loop motor control algorithm may be configured for generating PWM commands.
- the PWM commands may be, e.g., a series of uniform amplitude voltage pulses that are used to measure the command input into the motor.
- the PWM commands may be coupled to the electric motor 170 to power a drive mechanism 48 .
- An embodiment of the motor control algorithm may be a velocity loop algorithm.
- Such a velocity loop algorithm can be a proportional-integral-derivative (PID) loop in which motor velocity is the controlled output.
- a value of the PWM commands may be proportional to a load on the electric motor 170 .
- the load may differ greatly, depending on the presence or absence of an infusion cartridge 16 . In the case where the infusion cartridge 16 is absent, a smaller load may indicate this absence.
- the processor 42 may also include additional programming to allow the processor 42 to learn user preferences and/or user characteristics and/or user history data. For instance, to implement changes in use, suggestions based on detected trends, such as, weight gain or loss, and may include programming allowing the device to generate reports, such as user history, compliance, trending, and/or other such data.
- infusion pump embodiments of the disclosure may include a “power off” or “suspend” function for suspending one or more functions of the device, such as, suspending a delivery protocol, and/or for powering off the device or the delivery mechanism thereof.
- two or more processors may be used for controller functions of the infusion pumps, including a high power processor and a low power processor used to maintain programming and pumping functions in low power mode in order to, e.g., save battery life.
- Housing 26 of the infusion pump 12 may be functionally associated with an interchangeable and a removable glucose meter 20 and/or infusion cartridge 16 .
- the infusion cartridge 16 may have an outlet port 54 that may be connected to an infusion set (not shown) via an infusion set connector 18 (as shown in FIG. 2 ).
- the method 200 includes detecting the presence or absence of an infusion cartridge in an infusion pump.
- method 200 may include two phases, a calibration phase 210 and a pumping phase 220 .
- Method 200 may start the PWM calibration phase 210 at operation S 211 .
- an infusion cartridge may be installed in an infusion pump such as, for example, as described above.
- an infusion cartridge loading sequence may be initiated. During the loading sequence an electric infusion pump motor, propelling a drive mechanism, may engage a fluid delivery mechanism within the infusion cartridge. The engaged fluid delivery mechanism may represent a specific load on the infusion pump motor.
- PWM commands applied on the infusion pump motor during the loading sequence may be recorded into memory. For example, the PWM commands may have a percent/value ranging from 20% to 80%.
- an average value of the recorded PWM commands may be calculated.
- a value threshold of the PWM commands may be set to be the average value of the recorded PWM commands may be, for example, 52%. Because the PWM configuration procedure 210 can be done each time a cartridge is loaded, the threshold can be set at an appropriate value for each specific cartridge. This is advantageous because the load that each cartridge imparts on the motor can vary greatly.
- a pumping phase 220 can be begun.
- applied values of the operational PWM commands may be recorded and the average values of those operational PWM commands may be calculated.
- the PWM commands can be recorded and averaged for the duration of each distinct motor move.
- the average value of the operational PWM commands may be compared to the threshold value of the PWM commands. For example, the average value may be somewhere between 40% and 90%.
- an average value of the operational PWM commands is smaller, by a predetermined amount, than the value of the threshold PWM commands, a missing infusion cartridge indication/warning may be generated in operation 225 , and the pumping may be halted.
- the average value of more than one motor move must deviate from the threshold to generate an alarm.
- the alarm is generated if two motor moves in a row generate an average PWM value greater that deviate from the threshold by the predetermined amount.
- the number of motor move values that must cross the threshold to generate an alarm can be adjusted to vary the sensitivity of the alarm.
- the pumping may continue in operation 221 .
- the predetermined amount may be 10%.
- the predetermined value may be selected and set differently based on a selected pumping speed. For example, for a low pumping speed the predetermined value may be in the range of 20%-40% of the value of the threshold PWM command, for a high pumping speed the predetermined value may be in the range of 40%-60% of the value of the threshold PWM command.
- this loop 220 can be conducted continuously in order to indicate that a cartridge is absent as soon as possible when a cartridge is dislodged or removed.
- FIG. 4 depicts an embodiment of portion of an infusion cartridge such as infusion cartridge 16 including the delivery mechanism 120 , as well as a portion of the drive mechanism 48 of an infusion pump such as infusion pump 12 with which the method 200 described above can be employed.
- the delivery mechanism 120 may be configured to deliver fluid from a collapsible drug delivery reservoir 68 via a collapsible or variable volume element of a spool 106 .
- the variable volume elements may include constrained variable volume elements that are mechanically constrained to vary between a minimum volume and a maximum volume.
- the delivery mechanism 120 may include a delivery mechanism body 102 , or housing, and an axial bore 104 disposed in the delivery mechanism body 102 .
- the axial bore 104 may have a substantially round transverse cross section that may include a distal end 144 , a proximal end 148 disposed towards the drive mechanism 48 of the infusion pump system 100 , a reservoir inlet port 108 , a fluid outlet port 114 , a vent inlet port 112 , and a vent outlet port 116 .
- the spool 106 may also have a substantially round transverse cross section, which may be slidingly disposed within the axial bore 104 and may form a constrained variable volume 122 and a second vented volume 154 with the axial bore 104 .
- the drive mechanism 48 may include a rack and pinion mechanism 174 actuated by an electric motor 170 through a gear box 172 .
- the constrained variable volume 122 of the delivery mechanism 120 may be positionable to overlap the reservoir inlet port 108 independent of an overlap of the fluid outlet port 114 .
- the constrained variable volume 122 may be formed between a first seal 140 around the spool 106 , a second seal 142 around the spool 106 , an outer surface of the spool body between the first and second seal 140 and 142 and an interior surface of the axial bore 104 between the first and second seal 140 and 142 .
- the first and second seals 140 and 142 are axially moveable relative to each other so as to increase a volume of the constrained variable volume 122 when the first and second seals 140 and 142 are moved away from each other, and decrease the constrained variable volume 122 when the first and second seals 140 and 142 are moved closer together.
- the second seal 142 may be disposed on a proximal section 134 of the spool 106 and may move in conjunction with movement of the proximal section 134 of the spool 106 .
- a proximal end of the spool 136 may be coupled to a ball portion 178 of a drive shaft 176 of the drive mechanism 48 of the infusion pump 12 .
- the drive mechanism 48 may include a rack and pinion mechanism 174 actuated by an electric motor 170 through a gear box 172 .
- the second seal 142 may move or translate axially in step with axial translation of the spool 106 and drive shaft 176 .
- the first seal 140 may be disposed on a distal section 128 of the spool 106 which may be axially displaceable with respect to the main section 190 of the spool 106 .
- the distal section 128 of the spool 106 may be coupled to the main section of the spool by an axial extension 156 that may be mechanically captured by a cavity 158 in the main section 132 of the spool 106 .
- This configuration may impart a predetermined amount of controlled axial movement between the distal section 128 of the spool and the main section 132 of the spool 106 and may translate the constrained variable volume 122 from the reservoir inlet port 108 to the fluid outlet port 114 .
- This configuration may expand or contract the constrained variable volume 112 of the spool 106 by exerting translational axial force through a boundary section of the constrained variable volume 122 .
- a volume of a “bucket” of fluid dispensed by a complete and full dispense cycle of the spool 106 may be approximately equal to the cross-sectional area of the axial bore 104 multiplied by the length of displacement of the captured axial extension of the spool for the distal section 128 .
- the complete bucket of fluid may also be dispensed in smaller sub-volumes in increments as small as a resolution of the drive mechanism 48 allows.
- a dispense volume or bucket defined by the constrained variable volume 122 of the delivery mechanism 120 may be divided into about 10 to about 100 sub-volumes to be delivered or dispensed.
- the maximum axial displacement between the distal section 128 and main section of the spool 132 may range from about 0.01 inch to about 0.04 inch; more specifically, from about 0.018 inch to about 0.022 inch.
- the axial bore 104 of the delivery mechanism may have a transverse dimension or diameter ranging from about 0.04 inches to about 0.5 inches; more specifically, from about 0.08 inches to about 0.15 inches.
- the spool 106 may have a length ranging from about 10 mm to about 40 mm; more specifically, from about 15 mm to about 20 mm.
- the spool 106 and housing of the delivery mechanism 48 may be made from any suitable material or materials, including polymers or plastics such as polycarbonate, PEEK, thermoplastics, cyclic olefin copolymer, and the like.
- the seals disposed on the spool may have an outer transverse dimension or diameter that may be slightly larger than that of the spool 106 .
- the seals on the spool may have an axial thickness ranging from about 0.01 inches to about 0.03 inches and may be made from materials such as butyl, silicone, polyurethanes or the like having a shore hardness ranging from about 65A to about 75A and, more specifically, about 70A.
- a second vented volume 154 of the delivery mechanism 120 may be formed by the spool 106 and axial bore 104 of the delivery mechanism 48 .
- the second vented volume 154 may be formed by a third seal 150 disposed around the spool 106 and a fourth seal 152 also disposed around the spool and axially separated from the third seal 150 .
- the axial separation between the third and fourth seals 150 and 152 forming the second vented volume 154 may be greater than the axial separation between the vent inlet port 112 and vent outlet port 116 of the axial bore 104 in some instances.
- the second vented volume 154 may be formed by an outside surface of the spool 106 between the third and fourth seals 150 and 152 and an inside surface of the axial bore 104 between the third and fourth seals 150 and 152 .
- the second vented volume 154 may be axially displaceable with the movement of the spool 106 and may also be positionable by such axial displacement in order to simultaneously overlap the second vented volume 154 with the vent inlet port 112 and the vent outlet port 116 of the axial bore 104 .
- Such an overlap of both the vent inlet port 112 and the vent outlet port 116 may put these ports in fluid communication with each other, and may allow an equilibration of pressure between the first vented volume 80 of the infusion cartridge 16 and the environment surrounding the vent outlet port 116 .
- vent outlet port 116 may be in communication with the atmosphere and air may pass from the environment surrounding the vent outlet port 116 , through the second vented volume 154 of the axial bore 104 , and into the first vented volume 80 to replace the fluid dispensed subsequent to the last vent cycle.
- vent inlet port 112 and vent outlet port 116 do not share a common volume formed by the spool 106 and axial bore 104 of the delivery mechanism 120 , they are typically isolated and no venting of the first vented volume 80 may take place.
- the spool 106 defines one or more volumes between the spool 106 , the axial bore 104 and the circumferential seals 140 , 142 , 150 and 152 disposed on the spool of the delivery mechanism 120 .
- the spool 106 is typically translated in a proximal and distal direction in order to move the volumes into and out of communication with the various ports of the axial bore 104 .
- This axial movement in alternating proximal and distal directions of the spool 106 within the axial bore 104 may be used to put the various ports in fluid communication with translatable volumes of the delivery mechanism 120 .
- the spool 106 and the circumferential seals 140 , 142 , 150 and 152 disposed about the spool 106 may move smoothly within the axial bore 104 of the delivery mechanism 120 while maintaining a seal between an outside surface of the spool 106 and an inside surface of the axial bore 104 . It may also be desirable for the circumferential seals 140 , 142 , 150 and 152 disposed on the spool 106 to move axially back and forth within the axial bore 104 while maintaining a seal and with a minimum of friction. Achieving these features of the spool 106 may be facilitated with the use of particular seal configurations or gland configurations used to house the seals of the spool embodiments.
- the delivery mechanism 120 may be configured to deliver fluid from the reservoir 68 .
- the delivery mechanism 120 may include a delivery mechanism body 102 , or housing, and the axial bore 104 disposed in the delivery mechanism body 102 .
- the axial bore 104 may have a substantially round transverse cross section.
- the spool 106 may also have a substantially round transverse cross section, and may be slidingly disposed within the axial bore 104 .
- the drive mechanism 48 may include a rack and pinion mechanism 174 actuated by an electric motor 170 through a gear box 172 .
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
- This application is a continuation of application Ser. No. 13/837,661 filed Mar. 15, 2013, which is hereby fully incorporated herein by reference.
- There are many applications in academic, industrial, and medical fields, as well as others, that benefit from devices and methods that are capable of accurately and controllably delivering fluids, including liquids and gases that have a beneficial effect when administered in known and controlled quantities. Such devices and methods are particularly useful in the medical field where treatments for many patients include the administration of a known amount of a substance at predetermined intervals.
- Insulin-injecting pumps have been developed for the administration of insulin for those suffering from both type I and II diabetes. Continuous subcutaneous insulin injection and/or infusion therapy with portable infusion device has been adapted for the treatment of diabetes. Such therapy may include the regular and/or continuous injection or infusion of insulin into the skin of a person suffering from diabetes and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. Such pumps can be ambulatory/portable infusion pumps that are worn by the user that may use replaceable cartridges. Examples of such pumps and various features that can be associated with such pumps include those disclosed in U.S. patent application Ser. No. 13/557,163, U.S. patent application Ser. No. 12/714,299, U.S. patent application Ser. No. 12/538,018, U.S. Provisional Patent Application No. 61/655,883, U.S. Provisional Patent Application No. 61/656,967 and U.S. Pat. No. 8,287,495, each of which is incorporated herein by reference.
- There are, however, some drawbacks associated with the use of subcutaneous injection syringes and/or some currently available infusion pumps for the delivery of insulin and other medicaments. Some commercially available pumps may have an interchangeable infusion cartridge containing insulin and/or other medicaments. The correct attachment of this interchangeable infusion cartridge is important for the proper delivery of medicament. For instance, the cartridge may inadvertently become detached or may not be attached to the pump, resulting in possible inaccuracies in treatment and other issues.
- Therefore, there is a need for a system and a method for detecting the presence or absence of the infusion cartridge in the infusion pump.
- Disclosed herein are systems and methods for detecting the presence of an interchangeable infusion cartridge in an infusion pump and particularly in a portable or ambulatory infusion pump. In some embodiments, the method may include installing an infusion cartridge in an infusion pump, initiating an infusion cartridge loading sequence, recording loading pulse width modulation (PWM) commands applied to an infusion pump motor, setting a value of threshold PWM commands, comparing values of operational PWM commands applied during pumping operations to the value of the threshold PWM commands, and generating a missing cartridge indication whenever the value of an operational PWM command drops below the value of the threshold PWM commands by a predetermined amount.
- In some embodiments an infusion system is provided. The infusion system may be configured for detecting a presence or absence of an infusion cartridge. The infusion system may include an infusion cartridge and an infusion pump. The infusion cartridge may include a delivery mechanism for effectuating delivery of fluid having an axial bore, a spool which may be disposed within the axial bore and axially translatable within the axial bore, and a drug delivery reservoir for storing fluid. The infusion pump may include a drive mechanism and a processor. The processor may be coupled to a memory configured for receiving input data from the memory and using input data for generating operational parameters for the infusion system. Programming may be stored in the memory for execution by a processor to control a closed-loop motor control algorithm. The closed-loop motor control algorithm may be configured for generating PWM commands that operate a motor of the drive mechanism, and to indicate an absence of the infusion cartridge if the value of the operational PWM command falls below the predetermined value the threshold PWM commands.
- Certain embodiments are described further in the following description, examples, claims, and drawings. These features of embodiments will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings.
-
FIG. 1 is a flowchart illustrating a method embodiment for detecting the presence of an interchangeable infusion cartridge in an infusion pump. -
FIG. 2 is an exploded view of an embodiment of an infusion cartridge and an infusion pump with the infusion cartridge removed from the infusion pump. -
FIG. 3 is a block diagram representing an embodiment of an infusion pump. -
FIG. 4 is an elevation view in partial section of a delivery mechanism embodiment of the infusion cartridge embodiment ofFIG. 2 coupled to a drive mechanism embodiment. - Provided herein are systems, devices and methods for continuous or semi-continuous monitoring of the absence or presence of an interchangeable infusion cartridge in an infusion pump, and particularly in a portable or ambulatory infusion pump utilizing a replaceable cartridge containing insulin and/or other medicaments for the treatment of diabetes. Some embodiments may include advances in the internal components, the control circuitry, and improvements in a user interface of the systems and devices. The advances may allow for a safer and more accurate delivery of medicament to a patient than is currently attainable today from other devices, systems, and methods. Although embodiments described herein may be discussed in the context of the controlled delivery of insulin, delivery of other medicaments, including, for example, glucagon, pramlintide, etc., as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, or any other suitable indication or application. Non-medical applications are also contemplated.
- It should be noted that labels associated with operations described herein do not necessarily represent an order in a sequence; rather, they are used only to uniquely identify each operation. The words “loaded”, “written”, and “programmed” are used interchangeably in this document when they refer to a processor or a memory device. The terms “pump” and “infusion pump” may be used interchangeably throughout the document as may be the terms “fluid” and “liquid medicament.” In addition, the terms “pulse width modulation (PWM) commands” and “PWM commands” interchangeably represent a series of electrical pulses provided to power an electric motor of the infusion pump. A value of PWM commands generally represents a duty cycle of the series of pulses during a command sequence. For example, if the PWM is 100% with an input voltage of 3.0 volts, the output will be 3.0 volts. If the PWM command is 50%, the output voltage of the same 3.0 volt input would be 1.5 volts.
-
FIG. 2 depicts an embodiment of aninfusion pump system 100 with aninfusion cartridge 16 detached from the full-featuredinfusion pump device 12. Thepump 12 can include anattachment mechanism 64, positioned within thefirst receiving slot 22 that corresponds to areceiving mechanism 62 at an end of theinfusion cartridge 16. The attachment and receiving mechanisms can be configured to removably couple to each other to provide for an interchange of cartridges within theslot 22. The coupling keeps an interior of the cartridge and interior of the pump sealed from the surrounding environment such that fluid is retained within the volumes even under significant pressure. This attachment embodiment may be configured to produce a leak free detachable coupling that can withstand significant pressure. Thereceiving mechanism 62 may be configured to detachably couple with theattachment mechanism 64 such that theinfusion cartridge 16 may be removably attached to thehousing 26 of theinfusion pump 12 for fluid delivery. In this embodiment, theattachment mechanism 64 may include apneumatic tap 66 having an O-ring or other sealing device. Thecorresponding receiving mechanism 62 may include a port through which thepneumatic tap 66 may be inserted. Areservoir fill port 76 may be disposed on a top portion of theinfusion cartridge 16. In some cases, the desired fluid may be manually dispensed from the interior volume of a syringe or other source, through the reservoir fillport 76 and into the interior volume of theinfusion cartridge 16. -
FIG. 3 illustrates a block diagram of some features that may be incorporated within thehousing 26 of theinfusion pump 12. Theinfusion pump 12 may include amemory device 30, a transmitter/receiver 32, analarm 34, aspeaker 36, a clock/timer 38, aninput device 40, aprocessor 42, a user interface such as a graphical user interface (GUI) 60 having a touchsensitive screen 46 with input capability, adrive mechanism 48, and anestimator device 52. Thememory device 30 may be coupled to theprocessor 42 to receive and store input data, and to communicate that data to theprocessor 42. The input data may include user input data and sensor input data. The input data from thememory device 30 may be used to generate operational parameters for theinfusion pump 12. TheGUI 60 may be configured for displaying a request for the user to input data, for receiving user input data in response to the request, and communicating that data to the memory. TheGUI 60 can also be configured to display a missing infusion cartridge indication/warning as discussed herein. - The
processor 42 can function to control the overall operation of the pump.Processor 42 may communicate with and/or otherwise control the drive mechanism, output/display, memory, transmitter/receiver, and the like.Processor 42 of the infusion pump may communicate with a processor of another device, such as a continuous glucose monitor, a remote controller/commander, etc.Processor 42 may include programming that can control the infusion of insulin or other medicament from the cartridge, the data to be displayed by the display, the data to be transmitted via the transmitter, etc. Part of the programming may be configured to control anelectric motor 170 depicted inFIG. 4 .Processor 42 may also include programming that may allow the processor to receive signals and/or other data from an input device, such as a sensor sensing pressure, temperature, and the like. Theprocessor 42 may be included as a part ofinfusion pump 12 or may be used in conjunction therewith. - According to an embodiment, a motor control program may be stored in the
memory 30 for retrieval by theprocessor 42 to operate a closed-loop motor control algorithm. The closed-loop motor control algorithm may be configured for generating PWM commands. The PWM commands may be, e.g., a series of uniform amplitude voltage pulses that are used to measure the command input into the motor. The PWM commands may be coupled to theelectric motor 170 to power adrive mechanism 48. An embodiment of the motor control algorithm may be a velocity loop algorithm. Such a velocity loop algorithm can be a proportional-integral-derivative (PID) loop in which motor velocity is the controlled output. A value of the PWM commands may be proportional to a load on theelectric motor 170. The load may differ greatly, depending on the presence or absence of aninfusion cartridge 16. In the case where theinfusion cartridge 16 is absent, a smaller load may indicate this absence. - The
processor 42 may also include additional programming to allow theprocessor 42 to learn user preferences and/or user characteristics and/or user history data. For instance, to implement changes in use, suggestions based on detected trends, such as, weight gain or loss, and may include programming allowing the device to generate reports, such as user history, compliance, trending, and/or other such data. Additionally, infusion pump embodiments of the disclosure may include a “power off” or “suspend” function for suspending one or more functions of the device, such as, suspending a delivery protocol, and/or for powering off the device or the delivery mechanism thereof. For some embodiments, two or more processors may be used for controller functions of the infusion pumps, including a high power processor and a low power processor used to maintain programming and pumping functions in low power mode in order to, e.g., save battery life. -
Housing 26 of theinfusion pump 12 may be functionally associated with an interchangeable and aremovable glucose meter 20 and/orinfusion cartridge 16. Theinfusion cartridge 16 may have anoutlet port 54 that may be connected to an infusion set (not shown) via an infusion set connector 18 (as shown inFIG. 2 ). - Referring now to
FIG. 1 , a flowchart depicting a top-level view of amethod 200 according to embodiments of the present disclosure is illustrated. Themethod 200 includes detecting the presence or absence of an infusion cartridge in an infusion pump. In somecases method 200 may include two phases, acalibration phase 210 and apumping phase 220. -
Method 200 may start thePWM calibration phase 210 at operation S211. In operation S211, an infusion cartridge may be installed in an infusion pump such as, for example, as described above. In operation S212, an infusion cartridge loading sequence may be initiated. During the loading sequence an electric infusion pump motor, propelling a drive mechanism, may engage a fluid delivery mechanism within the infusion cartridge. The engaged fluid delivery mechanism may represent a specific load on the infusion pump motor. In operation S213, PWM commands applied on the infusion pump motor during the loading sequence may be recorded into memory. For example, the PWM commands may have a percent/value ranging from 20% to 80%. In operation S214, an average value of the recorded PWM commands may be calculated. In operation S215, a value threshold of the PWM commands may be set to be the average value of the recorded PWM commands may be, for example, 52%. Because thePWM configuration procedure 210 can be done each time a cartridge is loaded, the threshold can be set at an appropriate value for each specific cartridge. This is advantageous because the load that each cartridge imparts on the motor can vary greatly. - After a threshold value has been established for a particular cartridge, a
pumping phase 220 can be begun. In operations S221 and S222, during thepump phase 220, applied values of the operational PWM commands may be recorded and the average values of those operational PWM commands may be calculated. The PWM commands can be recorded and averaged for the duration of each distinct motor move. In operations S223 and S224, during each subsequent motor move in a pumping cycle, the average value of the operational PWM commands may be compared to the threshold value of the PWM commands. For example, the average value may be somewhere between 40% and 90%. - If an average value of the operational PWM commands is smaller, by a predetermined amount, than the value of the threshold PWM commands, a missing infusion cartridge indication/warning may be generated in
operation 225, and the pumping may be halted. In some embodiments, the average value of more than one motor move must deviate from the threshold to generate an alarm. In one embodiment, the alarm is generated if two motor moves in a row generate an average PWM value greater that deviate from the threshold by the predetermined amount. In certain embodiments, the number of motor move values that must cross the threshold to generate an alarm can be adjusted to vary the sensitivity of the alarm. If an average value of the operational PWM commands is larger, by the predetermined value, than the value of threshold PWM commands, the pumping may continue inoperation 221. In one example, the predetermined amount may be 10%. Thus, in the example in which the threshold value was 52%, of the average value of the operational commands is below 42%, the alarm is generated. - The predetermined value may be selected and set differently based on a selected pumping speed. For example, for a low pumping speed the predetermined value may be in the range of 20%-40% of the value of the threshold PWM command, for a high pumping speed the predetermined value may be in the range of 40%-60% of the value of the threshold PWM command. In one embodiment, this
loop 220 can be conducted continuously in order to indicate that a cartridge is absent as soon as possible when a cartridge is dislodged or removed. -
FIG. 4 depicts an embodiment of portion of an infusion cartridge such asinfusion cartridge 16 including thedelivery mechanism 120, as well as a portion of thedrive mechanism 48 of an infusion pump such as infusion pump 12 with which themethod 200 described above can be employed. Thedelivery mechanism 120 may be configured to deliver fluid from a collapsibledrug delivery reservoir 68 via a collapsible or variable volume element of aspool 106. For the embodiments discussed herein, the variable volume elements may include constrained variable volume elements that are mechanically constrained to vary between a minimum volume and a maximum volume. Thedelivery mechanism 120 may include a delivery mechanism body 102, or housing, and anaxial bore 104 disposed in the delivery mechanism body 102. Theaxial bore 104, may have a substantially round transverse cross section that may include adistal end 144, aproximal end 148 disposed towards thedrive mechanism 48 of theinfusion pump system 100, areservoir inlet port 108, afluid outlet port 114, a vent inlet port 112, and avent outlet port 116. Thespool 106 may also have a substantially round transverse cross section, which may be slidingly disposed within theaxial bore 104 and may form a constrainedvariable volume 122 and a second ventedvolume 154 with theaxial bore 104. Thedrive mechanism 48 may include a rack andpinion mechanism 174 actuated by anelectric motor 170 through agear box 172. - The constrained
variable volume 122 of thedelivery mechanism 120 may be positionable to overlap thereservoir inlet port 108 independent of an overlap of thefluid outlet port 114. The constrainedvariable volume 122 may be formed between afirst seal 140 around thespool 106, asecond seal 142 around thespool 106, an outer surface of the spool body between the first andsecond seal axial bore 104 between the first andsecond seal second seals variable volume 122 when the first andsecond seals variable volume 122 when the first andsecond seals - The
second seal 142 may be disposed on aproximal section 134 of thespool 106 and may move in conjunction with movement of theproximal section 134 of thespool 106. A proximal end of thespool 136 may be coupled to aball portion 178 of adrive shaft 176 of thedrive mechanism 48 of theinfusion pump 12. Thedrive mechanism 48 may include a rack andpinion mechanism 174 actuated by anelectric motor 170 through agear box 172. As such, thesecond seal 142 may move or translate axially in step with axial translation of thespool 106 and driveshaft 176. Thefirst seal 140, however, may be disposed on adistal section 128 of thespool 106 which may be axially displaceable with respect to the main section 190 of thespool 106. Thedistal section 128 of thespool 106 may be coupled to the main section of the spool by anaxial extension 156 that may be mechanically captured by acavity 158 in themain section 132 of thespool 106. This configuration may impart a predetermined amount of controlled axial movement between thedistal section 128 of the spool and themain section 132 of thespool 106 and may translate the constrainedvariable volume 122 from thereservoir inlet port 108 to thefluid outlet port 114. This configuration may expand or contract the constrained variable volume 112 of thespool 106 by exerting translational axial force through a boundary section of the constrainedvariable volume 122. - For some embodiments, a volume of a “bucket” of fluid dispensed by a complete and full dispense cycle of the
spool 106 may be approximately equal to the cross-sectional area of theaxial bore 104 multiplied by the length of displacement of the captured axial extension of the spool for thedistal section 128. The complete bucket of fluid may also be dispensed in smaller sub-volumes in increments as small as a resolution of thedrive mechanism 48 allows. For some embodiments, a dispense volume or bucket defined by the constrainedvariable volume 122 of thedelivery mechanism 120 may be divided into about 10 to about 100 sub-volumes to be delivered or dispensed. In some cases, the maximum axial displacement between thedistal section 128 and main section of thespool 132 may range from about 0.01 inch to about 0.04 inch; more specifically, from about 0.018 inch to about 0.022 inch. - For some embodiments, the
axial bore 104 of the delivery mechanism may have a transverse dimension or diameter ranging from about 0.04 inches to about 0.5 inches; more specifically, from about 0.08 inches to about 0.15 inches. For some embodiments, thespool 106 may have a length ranging from about 10 mm to about 40 mm; more specifically, from about 15 mm to about 20 mm. Thespool 106 and housing of thedelivery mechanism 48 may be made from any suitable material or materials, including polymers or plastics such as polycarbonate, PEEK, thermoplastics, cyclic olefin copolymer, and the like. In some cases, the seals disposed on the spool may have an outer transverse dimension or diameter that may be slightly larger than that of thespool 106. In some instances, the seals on the spool may have an axial thickness ranging from about 0.01 inches to about 0.03 inches and may be made from materials such as butyl, silicone, polyurethanes or the like having a shore hardness ranging from about 65A to about 75A and, more specifically, about 70A. - In some instances, a second vented
volume 154 of thedelivery mechanism 120 may be formed by thespool 106 andaxial bore 104 of thedelivery mechanism 48. The second ventedvolume 154 may be formed by athird seal 150 disposed around thespool 106 and afourth seal 152 also disposed around the spool and axially separated from thethird seal 150. The axial separation between the third andfourth seals volume 154 may be greater than the axial separation between the vent inlet port 112 and ventoutlet port 116 of theaxial bore 104 in some instances. The second ventedvolume 154 may be formed by an outside surface of thespool 106 between the third andfourth seals axial bore 104 between the third andfourth seals - The second vented
volume 154 may be axially displaceable with the movement of thespool 106 and may also be positionable by such axial displacement in order to simultaneously overlap the second ventedvolume 154 with the vent inlet port 112 and thevent outlet port 116 of theaxial bore 104. Such an overlap of both the vent inlet port 112 and thevent outlet port 116 may put these ports in fluid communication with each other, and may allow an equilibration of pressure between the first ventedvolume 80 of theinfusion cartridge 16 and the environment surrounding thevent outlet port 116. In most cases, thevent outlet port 116 may be in communication with the atmosphere and air may pass from the environment surrounding thevent outlet port 116, through the second ventedvolume 154 of theaxial bore 104, and into the first ventedvolume 80 to replace the fluid dispensed subsequent to the last vent cycle. When the vent inlet port 112 and ventoutlet port 116 do not share a common volume formed by thespool 106 andaxial bore 104 of thedelivery mechanism 120, they are typically isolated and no venting of the first ventedvolume 80 may take place. - In operation, the
spool 106 defines one or more volumes between thespool 106, theaxial bore 104 and thecircumferential seals delivery mechanism 120. Thespool 106 is typically translated in a proximal and distal direction in order to move the volumes into and out of communication with the various ports of theaxial bore 104. This axial movement in alternating proximal and distal directions of thespool 106 within theaxial bore 104 may be used to put the various ports in fluid communication with translatable volumes of thedelivery mechanism 120. For reliable operation, it may be desirable in some circumstances for thespool 106 and thecircumferential seals spool 106 to move smoothly within theaxial bore 104 of thedelivery mechanism 120 while maintaining a seal between an outside surface of thespool 106 and an inside surface of theaxial bore 104. It may also be desirable for thecircumferential seals spool 106 to move axially back and forth within theaxial bore 104 while maintaining a seal and with a minimum of friction. Achieving these features of thespool 106 may be facilitated with the use of particular seal configurations or gland configurations used to house the seals of the spool embodiments. - The
delivery mechanism 120 may be configured to deliver fluid from thereservoir 68. Thedelivery mechanism 120 may include a delivery mechanism body 102, or housing, and theaxial bore 104 disposed in the delivery mechanism body 102. Theaxial bore 104 may have a substantially round transverse cross section. Thespool 106 may also have a substantially round transverse cross section, and may be slidingly disposed within theaxial bore 104. Thedrive mechanism 48 may include a rack andpinion mechanism 174 actuated by anelectric motor 170 through agear box 172. - With regard to the above detailed description, like reference numerals used therein may refer to like elements that may have the same or similar dimensions, materials, and configurations. While particular forms of embodiments have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the embodiments herein. Accordingly, it is not intended that the invention be limited by the forgoing detailed description.
- The entirety of each patent, patent application, publication, and document referenced herein is hereby incorporated by reference. Citation of the above patents, patent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these documents.
- Modifications may be made to the foregoing embodiments without departing from the basic aspects of the technology. Although the technology may have been described in substantial detail with reference to one or more specific embodiments, changes may be made to the embodiments specifically disclosed in this application, yet these modifications and improvements are within the scope and spirit of the technology. The technology illustratively described herein may suitably be practiced in the absence of any element(s) not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof and various modifications are possible within the scope of the technology claimed. Although the present technology has been specifically disclosed by representative embodiments and optional features, modification and variation of the concepts herein disclosed may be made, and such modifications and variations may be considered within the scope of this technology.
Claims (23)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/467,500 US11896799B2 (en) | 2013-03-15 | 2017-03-23 | System and method for detecting presence of an infusion cartridge in an infusion pump |
US18/410,623 US20240148966A1 (en) | 2013-03-15 | 2024-01-11 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/837,661 US20140276569A1 (en) | 2013-03-15 | 2013-03-15 | System and method for detecting presence of an infusion cartridge in an infusion pump |
US15/467,500 US11896799B2 (en) | 2013-03-15 | 2017-03-23 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/837,661 Continuation US20140276569A1 (en) | 2013-03-15 | 2013-03-15 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/410,623 Continuation US20240148966A1 (en) | 2013-03-15 | 2024-01-11 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Publications (2)
Publication Number | Publication Date |
---|---|
US20170246379A1 true US20170246379A1 (en) | 2017-08-31 |
US11896799B2 US11896799B2 (en) | 2024-02-13 |
Family
ID=51530788
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/837,661 Abandoned US20140276569A1 (en) | 2013-03-15 | 2013-03-15 | System and method for detecting presence of an infusion cartridge in an infusion pump |
US15/467,500 Active 2035-04-13 US11896799B2 (en) | 2013-03-15 | 2017-03-23 | System and method for detecting presence of an infusion cartridge in an infusion pump |
US18/410,623 Pending US20240148966A1 (en) | 2013-03-15 | 2024-01-11 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/837,661 Abandoned US20140276569A1 (en) | 2013-03-15 | 2013-03-15 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/410,623 Pending US20240148966A1 (en) | 2013-03-15 | 2024-01-11 | System and method for detecting presence of an infusion cartridge in an infusion pump |
Country Status (3)
Country | Link |
---|---|
US (3) | US20140276569A1 (en) |
EP (1) | EP2968745A4 (en) |
WO (1) | WO2014149475A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11554209B2 (en) | 2015-05-08 | 2023-01-17 | Triple Jump Israel Ltd. | Systems, apparatuses and methods for fluid infusion into a body |
US11596733B2 (en) | 2017-06-15 | 2023-03-07 | Triple Jump Israel Ltd. | Patch pump systems and apparatus for managing diabetes, and methods thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140276569A1 (en) | 2013-03-15 | 2014-09-18 | Tandem Diabetes Care, Inc. | System and method for detecting presence of an infusion cartridge in an infusion pump |
US9603995B2 (en) | 2013-03-15 | 2017-03-28 | Tandem Diabetes Care. Inc. | Device and method for setting therapeutic parameters for an infusion device |
US10279106B1 (en) | 2014-05-08 | 2019-05-07 | Tandem Diabetes Care, Inc. | Insulin patch pump |
CN107158513A (en) * | 2017-05-27 | 2017-09-15 | 余庆县人民医院 | Infusion bag with pressurizing unit |
US20200368430A1 (en) | 2019-05-21 | 2020-11-26 | Tandem Diabetes Care, Inc. | System and method for incorporating exercise into closed-loop diabetes therapy |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4194144A (en) * | 1977-07-05 | 1980-03-18 | Ncr Corporation | Constant velocity driving means |
US20100164727A1 (en) * | 2008-12-30 | 2010-07-01 | Medtronic Minimed, Inc. | Color detection system for detecting reservoir presence and content in device |
US20100211003A1 (en) * | 2007-09-17 | 2010-08-19 | Satish Sundar | High Precision Infusion Pumps |
US20110286008A1 (en) * | 2009-11-18 | 2011-11-24 | Roche Diagnostics International Ltd. | Device and methods for cartridge detection |
US20120259282A1 (en) * | 2010-12-22 | 2012-10-11 | Medtronic Minimed, Inc. | Fluid reservoir seating procedure for a fluid infusion device |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231616A (en) | 1989-04-06 | 1993-07-27 | Hewlett-Packard Company | Calibration of a cartridge handling device using mechanical sense of touch |
US5243983A (en) | 1990-12-14 | 1993-09-14 | Georgia Tech Research Corporation | Non-invasive blood glucose measurement system and method using stimulated raman spectroscopy |
US5676651A (en) | 1992-08-06 | 1997-10-14 | Electric Boat Corporation | Surgically implantable pump arrangement and method for pumping body fluids |
ES2154651T3 (en) | 1992-10-15 | 2001-04-16 | Gen Hospital Corp | INFUSION PUMP WITH ELECTRONICALLY CHARGABLE MEDICATIONS LIBRARY. |
US5482446A (en) | 1994-03-09 | 1996-01-09 | Baxter International Inc. | Ambulatory infusion pump |
US7647237B2 (en) | 1998-04-29 | 2010-01-12 | Minimed, Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
US7255680B1 (en) | 1999-10-27 | 2007-08-14 | Cardinal Health 303, Inc. | Positive pressure infusion system having downstream resistance measurement capability |
US6673033B1 (en) | 1999-11-24 | 2004-01-06 | Medrad, Inc. | Injectors, injector systems and injector control |
AR026914A1 (en) | 1999-12-11 | 2003-03-05 | Glaxo Group Ltd | MEDICINAL DISTRIBUTOR |
AU2001279282A1 (en) | 2000-07-07 | 2002-01-21 | Fluidsense Corporation | Pump cassette with controlled pump force |
US6582393B2 (en) | 2001-05-29 | 2003-06-24 | Therafuse, Inc. | Compensating drug delivery system |
US7220365B2 (en) | 2001-08-13 | 2007-05-22 | New Qu Energy Ltd. | Devices using a medium having a high heat transfer rate |
US7041082B2 (en) | 2002-02-28 | 2006-05-09 | Smiths Medical Md, Inc. | Syringe pump control systems and methods |
MXPA04012161A (en) | 2002-06-06 | 2005-04-19 | Johnson & Son Inc S C | Localized surface volatilization. |
EP2383470A1 (en) | 2002-10-09 | 2011-11-02 | Abbott Diabetes Care Inc. | Plunger pump actuated by a shape memory element |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
US6997202B2 (en) | 2002-12-17 | 2006-02-14 | Advanced Technology Materials, Inc. | Gas storage and dispensing system for variable conductance dispensing of gas at constant flow rate |
KR20060131945A (en) | 2004-03-30 | 2006-12-20 | 노보 노르디스크 에이/에스 | Actuator system comprising detection means |
WO2005094920A1 (en) | 2004-03-30 | 2005-10-13 | Novo Nordisk A/S | Actuator system comprising lever mechanism |
US7305975B2 (en) | 2004-04-23 | 2007-12-11 | Reddy Sam R | Evap canister purge prediction for engine fuel and air control |
US7507221B2 (en) | 2004-10-13 | 2009-03-24 | Mallinckrodt Inc. | Powerhead of a power injection system |
ATE414551T1 (en) | 2005-02-21 | 2008-12-15 | Novo Nordisk As | METHOD FOR ENSURE CONSTANT ENGINE SPEED IN AN INJECTION DEVICE |
US7563248B2 (en) | 2005-03-17 | 2009-07-21 | Smisson-Cartledge Biomedical Llc | Infusion fluid heat exchanger and cartridge |
US7905373B2 (en) | 2006-03-06 | 2011-03-15 | Deka Products Limited Partnership | System and method for generating a drive signal |
US7605710B2 (en) | 2006-08-18 | 2009-10-20 | Fresenius Medical Care Holdings, Inc. | Wetness sensor |
JP2008117482A (en) | 2006-11-06 | 2008-05-22 | Funai Electric Co Ltd | Reproducing device with built-in optical disk drive |
US20090107335A1 (en) | 2007-02-27 | 2009-04-30 | Deka Products Limited Partnership | Air trap for a medical infusion device |
US8562834B2 (en) | 2007-02-27 | 2013-10-22 | Deka Products Limited Partnership | Modular assembly for a portable hemodialysis system |
US8409441B2 (en) | 2007-02-27 | 2013-04-02 | Deka Products Limited Partnership | Blood treatment systems and methods |
US8032226B2 (en) | 2007-09-07 | 2011-10-04 | Asante Solutions, Inc. | User profile backup system for an infusion pump device |
US8287514B2 (en) | 2007-09-07 | 2012-10-16 | Asante Solutions, Inc. | Power management techniques for an infusion pump system |
EP2246080B1 (en) | 2007-10-12 | 2016-02-10 | DEKA Products Limited Partnership | An extracorporeal blood flow system |
CA3017406C (en) | 2008-01-23 | 2023-08-22 | Deka Products Limited Partnership | Fluid handling cassette for use with a peritoneal dialysis system |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
DK2136466T3 (en) | 2008-06-20 | 2011-02-28 | Hoffmann La Roche | Medical infusion system with pulse width modulation and safety circuit |
US8349174B2 (en) | 2008-07-23 | 2013-01-08 | Baxter International Inc. | Portable power dialysis machine |
US8226374B2 (en) | 2008-07-24 | 2012-07-24 | Nidec Motor Corporation | Variable motor drive system for a reservoir with circulating fluid |
EP2385851B1 (en) * | 2008-09-05 | 2015-02-18 | Roche Diagnostics GmbH | Skin-patch type infusion pump comprising a resonant buzzer |
AU2009293019A1 (en) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care Inc. | Solute concentration measurement device and related methods |
US8573027B2 (en) | 2009-02-27 | 2013-11-05 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
CA2964741C (en) | 2009-03-09 | 2019-10-29 | Thermedx, Llc | Surgical fluid management system |
WO2011014704A2 (en) | 2009-07-30 | 2011-02-03 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US8552880B2 (en) * | 2009-12-04 | 2013-10-08 | Smiths Medical Asd, Inc. | Guided user help system for an ambulatory infusion system |
US8287488B2 (en) * | 2009-12-08 | 2012-10-16 | Roche Diagnostics Operations, Inc. | Holographic occlusion detection system for infusion pumps |
US8430849B2 (en) * | 2010-09-24 | 2013-04-30 | Perqflo, Llc | Infusion pumps and plunger pusher position-responsive cartridge lock for infusion pumps |
US9216249B2 (en) * | 2010-09-24 | 2015-12-22 | Perqflo, Llc | Infusion pumps |
US20130053816A1 (en) | 2011-07-25 | 2013-02-28 | Tandem Diabetes Care, Inc. | Multi-reservoir infusion pump systems and methods |
US9603995B2 (en) | 2013-03-15 | 2017-03-28 | Tandem Diabetes Care. Inc. | Device and method for setting therapeutic parameters for an infusion device |
US20140276569A1 (en) | 2013-03-15 | 2014-09-18 | Tandem Diabetes Care, Inc. | System and method for detecting presence of an infusion cartridge in an infusion pump |
-
2013
- 2013-03-15 US US13/837,661 patent/US20140276569A1/en not_active Abandoned
-
2014
- 2014-02-26 WO PCT/US2014/018735 patent/WO2014149475A1/en active Application Filing
- 2014-02-26 EP EP14768610.9A patent/EP2968745A4/en not_active Withdrawn
-
2017
- 2017-03-23 US US15/467,500 patent/US11896799B2/en active Active
-
2024
- 2024-01-11 US US18/410,623 patent/US20240148966A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4194144A (en) * | 1977-07-05 | 1980-03-18 | Ncr Corporation | Constant velocity driving means |
US20100211003A1 (en) * | 2007-09-17 | 2010-08-19 | Satish Sundar | High Precision Infusion Pumps |
US20100164727A1 (en) * | 2008-12-30 | 2010-07-01 | Medtronic Minimed, Inc. | Color detection system for detecting reservoir presence and content in device |
US20110286008A1 (en) * | 2009-11-18 | 2011-11-24 | Roche Diagnostics International Ltd. | Device and methods for cartridge detection |
US20120259282A1 (en) * | 2010-12-22 | 2012-10-11 | Medtronic Minimed, Inc. | Fluid reservoir seating procedure for a fluid infusion device |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11554209B2 (en) | 2015-05-08 | 2023-01-17 | Triple Jump Israel Ltd. | Systems, apparatuses and methods for fluid infusion into a body |
US11596733B2 (en) | 2017-06-15 | 2023-03-07 | Triple Jump Israel Ltd. | Patch pump systems and apparatus for managing diabetes, and methods thereof |
Also Published As
Publication number | Publication date |
---|---|
EP2968745A4 (en) | 2016-12-21 |
US20140276569A1 (en) | 2014-09-18 |
US20240148966A1 (en) | 2024-05-09 |
US11896799B2 (en) | 2024-02-13 |
WO2014149475A1 (en) | 2014-09-25 |
EP2968745A1 (en) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240148966A1 (en) | System and method for detecting presence of an infusion cartridge in an infusion pump | |
US9962486B2 (en) | System and method for detecting occlusions in an infusion pump | |
US20230414863A1 (en) | Device and method for setting therapeutic parameters for an infusion device | |
US11324898B2 (en) | System and method for infusion set dislodgement detection | |
US9555186B2 (en) | Infusion pump system with disposable cartridge having pressure venting and pressure feedback | |
US20170035962A1 (en) | Infusion system and methods | |
US20130053816A1 (en) | Multi-reservoir infusion pump systems and methods | |
US8034019B2 (en) | Dual microcontroller-based liquid infusion system | |
JP5506780B2 (en) | System, apparatus and method for delivering fluid | |
US20110028937A1 (en) | Automated fluid flow control system | |
JP2023161011A (en) | Reservoir having low liquid amount sensor | |
US20140373968A1 (en) | Filling Device and Controller for Filling an Administration Container | |
US20230398286A1 (en) | Systems and methods for substantially continuous intravenous infusion of the same or substantially the same medical fluid with fluid source replacements | |
AU2023226628B2 (en) | Drug delivery device | |
US20230108800A1 (en) | Infusion pump with multiple reservoirs | |
CA3230689A1 (en) | Clutch device for compact positive displacement pump of a wearable drug delivery device | |
JP2024519076A (en) | Miniature positive displacement pump for wearable drug delivery devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TANDEM DIABETES CARE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KRUSE, GEOFFREY;REEL/FRAME:042452/0868 Effective date: 20130523 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:TANDEM DIABETES CARE, INC.;REEL/FRAME:060179/0100 Effective date: 20220518 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: TANDEM DIABETES CARE, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:066880/0918 Effective date: 20240319 |